शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEPanchsheel Organics Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 30 May, 2025 · 16:14 IST

AUDITED FINANCIAL RESULTS OF PANCHSHEEL ORGANICS LIMITED FOR THE QUARTER AND YEAR ENDED 31ST MARCH 2025

Related-party transactionsEBITDA margin compressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.6%Reaction day
₹150.05
prior close
₹148.05
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+1.5% vs market
Pharmaceuticals peers, median of 147sector-0.1%+1.8% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-4.0
10m
-2.7
15m
-2.3
30m
-2.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.6+0.1+1.5-0.1+1.8
Next day
+3.3-0.2+3.5-0.3+3.6
2d
+3.3+0.3+3.0-0.3+3.6
3d
+4.2+0.9+3.4+0.0+4.2
4d
+3.3+0.8+2.5+0.0+3.3
5d
+3.7+2.2+1.5+0.6+3.1
1w
+0.6+3.4-2.8+1.4-0.8
15d
-8.0-0.8-7.2-2.9-5.1
1m
-2.1+2.9-5.0+0.3-2.3
2m
+18.6+0.8+17.8-0.5+19.1
3m
+2.0+0.0+2.0-3.4+5.4
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Panchsheel Organics reported FY25 revenue from operations of Rs. 10,717.84 lakhs, up marginally from Rs. 10,521.87 lakhs in FY24 (~1.9% growth). However, Q4 FY25 revenue slipped to Rs. 2,837.39 lakhs versus Rs. 3,126.98 lakhs in Q4 FY24, a ~9% YoY decline. Net profit for FY25 stood at approximately Rs. 1,379 lakhs versus Rs. 1,411 lakhs in FY24, a slight dip, with basic EPS at Rs. 10.47 vs Rs. 10.71. The Board recommended a final dividend of Rs. 0.80 per share (face value Rs. 10). Operating cash flow dropped sharply from Rs. 957 lakhs to Rs. 383 lakhs, largely due to higher working capital absorption and a significant step-up in capital expenditure (Rs. 1,556 lakhs vs Rs. 989 lakhs). Auditor M/s Jayesh R. Shah & Co. issued an unmodified (clean) opinion on the results.

Likely market impact

Mixed signals for shareholders — flat top-line and slightly lower profits year-on-year, but the Board maintained a steady dividend and continued investing in capacity (higher capex). The sharp fall in operating cash flow despite stable profits may warrant attention, though the balance sheet remains debt-light and reserves grew to Rs. 12,069 lakhs.